Biora Therapeutics Inc (NAS:BIOR)
$ 0.678 0.02 (3.04%) Market Cap: 24.73 Mil Enterprise Value: 66.36 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 33/100

Q4 2023 Biora Therapeutics Inc Earnings Call Transcript

Mar 26, 2024 / 08:30PM GMT
Release Date Price: $1.33 (+9.02%)
Operator

Welcome to the Biora Therapeutics fourth quarter 2023 financial results call. (Operator Instructions) As a reminder, this conference is being recorded. I will now turn the call over to Chuck Padala, our Managing Director with LifeSci Advisors, Biora's Investor Relations firm.

Chuck Padala
Biora Therapeutics Inc - Managing Director

Thank you, operator. Good afternoon, and welcome to the Biora Therapeutics Fourth Quarter 2023 Corporate Update and Financial Results Conference Call. Joining me on the call are Adi Mohanty, Chief Executive Officer; Ariella Kelman, Chief Medical Officer; and Eric d'Esparbes, Chief Financial Officer.

Before I turn the call over to Mr. Mohanty, I'd like to remind you that today's call will include forward-looking statements within the meaning of the federal securities law, including, but not limited to the types of statements identified as forward-looking in our quarterly report on Form 10 K that we plan to file in the next few days at our subsequent reports filed with the SEC, which are available on our website in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot